Life Sciences Report March 2020 – Drug Safety

Clinical Professionals and Vacancysoft

March 2020

For Pharmaceuticals companies, 2020 faces its own unique challenges. Already there are multiple blockbuster drugs due to expire this year, including Lucentis produced by Roche & Novartis, along with Spyrcel. Now with the advent of the Coronavirus crisis, companies will be under pressure like never before to release a drug quickly that can act as a vaccine.

Therefore, we already see that drug safety vacancies have been continuously increasing across the EU27. Since 2018 the number of vacancies had increased by 24.8%. However, perhaps due to a Brexit drag, in the UK specifically, the number of pharmacovigilance vacancies has dropped by 5.8%.

To find out more about the latest trends in the Drug Safety, download the report now!

Yes, I want this report!

Yes, I would like to receive more information about your products, offers, and events. I understand I can unsubscribe at any time.*

When you provide the information above, we will use it to process your request as described in our Privacy Policy .

Related Posts

Banking Sector Report April 2020 – FINANCE ...   April 2020 This year was already set to be tumultuous for people in finance, as the final negotiations of Brexit took shape. The fact that ...
Fintech Sector Report April 2020 – THE UK FI...   April 2020 Now with the most at risk to Covid19 also being the ones who traditionally were the most reliant on counter services, the societ...